Histone deacetylase inhibitors with combined activity on class-I and classIIB histone deacetylases in combination with proteasome inhibitors

Details for Australian Patent Application No. 2007296256 (hide)

Owner Janssen Pharmaceutica NV

Inventors Janicot, Michel Marie Francois; Hellemans, Peter Willem Jan; Arts, Janine; Page, Martin John

Agent Shelston IP

Pub. Number AU-A-2007296256

PCT Pub. Number WO2008/031817

Priority 60/915,895 03.05.07 US; 06120726.2 15.09.06 EP

Filing date 11 September 2007

Wipo publication date 20 March 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/031817 Priority application(s): WO2008/031817

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296259-Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors

2007296250-Nitrate esters of aminoalcohols